Taiwan FDA registration 6767237f3de49a3e1e8131f199d54378

"Ti-Ho" hematocrit centrifuge (Non-Sterile)

TW: "鈦和" 血球容積測量離心機 (未滅菌)

Taiwan·Risk Class 1·MD·Titanium and Health Technology Co., Ltd. Zhonghe plant·Registered Mar 21, 2017 – Mar 21, 2022Expired

Registration details

Analysis ID: 6767237f3de49a3e1e8131f199d54378
License Form: Ministry of Health Medical Device Manufacturing No. 006646

Company information

Manufacturer: Titanium and Health Technology Co., Ltd. Zhonghe plant
Manufacturer Country: Taiwan, Province of China
Authorized Representative: Titanium and Health Technology Co., Ltd. Zhonghe plant

Product details

Intended Use: Limited to the first level identification range of the blood cell volume measurement device (B.6400) of the medical equipment management method.
Product Type (Level 1): B Hematology and pathology devices
Product Type (Level 2): B6400 Blood cell volume measurement device
Import Information: Produced in Taiwan, China

Dates and status

Registration Date: Mar 21, 2017
Expiry Date: Mar 21, 2022

About this record

Access comprehensive regulatory information for "Ti-Ho" hematocrit centrifuge (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 6767237f3de49a3e1e8131f199d54378 and manufactured by Titanium and Health Technology Co., Ltd. Zhonghe plant. The authorized representative in Taiwan is Titanium and Health Technology Co., Ltd. Zhonghe plant.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.